Search Results - KRAKOVER, Rikardo

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?

    Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? by Cotter, Gad, Shemesh, Eyal, Zehavi, Miriam, Dinur, Irit, Rudnick, Abraham, Milo, Olga, Vered, Zvi, Krakover, Rikardo, Kaluski, Edo, Kornberg, Abraham

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock a prospective randomized study

    LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock a prospective randomized study by COTTER, Gad, KALUSKI, Edo, MILO, Olga, BLATT, Alex, SALAH, Ahmed, HENDLER, Alberto, KRAKOVER, Rikardo, GOLICK, Ahuva, VERED, Zvi

    Published in European heart journal
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema

    RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema by Kaluski, Edo, Kobrin, Isaac, Zimlichman, Reuven, Marmor, Alon, Krakov, Oscar, Milo, Olga, Frey, Aline, Kaplan, Shoshana, Krakover, Rikardo, Caspi, Avi, Vered, Zvi, Cotter, Gad

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Characteristics and management of patients with acute coronary syndrome and normal or non-significant coronary artery disease: results from Acute Coronary Syndrome Israeli Survey (ACSIS) 2004-2010

    Characteristics and management of patients with acute coronary syndrome and normal or non-significant coronary artery disease: results from Acute Coronary Syndrome Israeli Survey (... by Minha, Sa'ar, Gottlieb, Shmuel, Magalhaes, Marco A, Gavrielov-Yusim, Natalie, Krakover, Rikardo, Goldenberg, Ilan, Vered, Zvi, Blatt, Alex

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    RITZ-5: Randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of Pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study

    RITZ-5: Randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of Pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study by KALUSKI, Edo, KOBRIN, Isaac, VERED, Zvi, COTTER, Gad, ZIMLICHMAN, Reuven, MARMOR, Alon, KRAKOV, Oscar, MILO, Olga, FREY, Aline, KAPLAN, Shoshana, KRAKOVER, Rikardo, CASPI, Avi

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study

    Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results... by Cotter, Gad, Cannon, Christopher P., McCabe, Carolyn H., Michowitz, Yoav, Kaluski, Edo, Charlesworth, Andrew, Milo, Olga, Bentley, Jane, Blatt, Alex, Krakover, Rikardo, Zimlichman, Reuven, Reisin, Leonardo, Marmor, Alon, Lewis, Basil, Vered, Zvi, Caspi, Avi, Braunwald, Eugene

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema

    High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema by Sharon, Ahuva, Shpirer, Isaac, Kaluski, Edo, Moshkovitz, Yaron, Milovanov, Olga, Polak, Roman, Blatt, Alex, Simovitz, Avi, Shaham, Ori, Faigenberg, Zvi, Metzger, Michael, Stav, David, Yogev, Robert, Golik, Ahuva, Krakover, Rikardo, Vered, Zvi, Cotter, Gad

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Outcome Of Patients With Cardiogenic Shock Treated By NO Synthase Inhibitors Is Predicted Only By Hemodynamic Response To Treatment And Not Baseline Characteristics. Results From The LINCS study

    Outcome Of Patients With Cardiogenic Shock Treated By NO Synthase Inhibitors Is Predicted Only By Hemodynamic Response To Treatment And Not Baseline Characteristics. Results From T... by Cotter, Gad, Milo, Olga, Kaluski, Edo, Blatt, Alex, Salah, Ahmed, Krakover, Rikardo, Golik, Ahuva, Vered, Zvi

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock

    LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock by Cotter, Gad, Kaluski, Edo, Milo, Olga, Blatt, Alex, Salah, Ahmed, Hendler, Alberto, Krakover, Rikardo, Golick, Ahuva, Vered, Zvi

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study

    RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study by Kaluski, Edo, Kobrin, Isaac, Zimlichman, Reuven, Marmor, Alon, Krakov, Oscar, Milo, Olga, Frey, Aline, Kaplan, Shoshana, Krakover, Rikardo, Caspi, Avi, Vered, Zvi, Cotter, Gad

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: